FOLH1 and prostate carcinoma: We performed a PubMed search focusing on the keywords “prostate cancer”, “metastatic castration-resistant prostate cancer”, “DNA damage repair pathways”, “ARS inhibitors”, “PARP inhibitors”, “immune checkpoint inhibitors”, “PSMA-targeting agents”, and “drug combinations”.